Shield Therapeutics plc (STX) — Cash Flow Reinvestment Rate
Latest as of June 2020:
0.00x
Shield Therapeutics plc (STX) has a Cash Flow Reinvestment Rate of 0.00x as of June 2020, reinvesting GBX2.00K (capex GBX2.00K ) from operating cash flow of GBX2.40 Million. Explore Shield Therapeutics plc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
GBX2.00K
Capex + Investments
Operating Cash Flow
GBX2.40 Million
GBX
Capital Expenditures
GBX2.00K
GBX
Annual Cash Flow Reinvestment Rate for Shield Therapeutics plc (None–None)
Year-by-year capital reinvestment analysis for Shield Therapeutics plc. For live market cap and broader valuation context, see Shield Therapeutics plc (STX) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow